| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-13 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-13 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-11 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-09 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-08 |